首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1547487

全球全基因組擴增市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Whole Genome Amplification Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球全基因組擴增市場需求預計將從 2023 年的 341 萬美元達到近 707 萬美元的市場規模，2024-2032 年研究期間複合年成長率為 8.44%。

全基因組擴增（WGA）是整個基因組被擴增的過程。過程開始時保留的奈克 DNA 量被轉換為微克擴增產物。它的工作原理是聚合酶鍊式反應，透過酶複製基因組樣本中的 DNA。 WGA 被認為是一種重要的工具，因為它可以藉助少量的基因組 DNA 來增加有限數量的 DNA 樣本。它對於研究生物體的基因非常有用，這是用保存的有限樣本完成的。該過程廣泛用於許多應用。

市場動態

全基因組擴增在各領域的應用不斷增加是推動WGA市場的關鍵因素。由於 WGA 擴大用於診斷遺傳性疾病和胚胎疾病、基因分型、法醫和舊 DNA 樣本分析，WGA 預計將出現良好的成長。此外，人們對 WGA 認知的提高、對臨床試驗和分子生物學應用的大量投資將有助於 WGA 市場的成長。然而，WGA 的結果可能會因用於定序、擴增和提取 DNA 的兩種不同技術（即 PCR WGA 和 REPLI-g）而有所不同，這一事實可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球全基因組擴增市場的每個細分市場進行了包容性評估。全基因組擴增產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

全基因組擴增市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按類型

單細胞 WGA 試劑盒
完整的 WGA 套件
WGA 再次擴增套件
WGA 和晶片 DNA 試劑盒
其他

按申請

藥物發現與開發
疾病診斷
農業與獸醫
研究
法證學
其他

按最終用戶

製藥與生物技術公司
合約研究
醫院和診所
研究與學術機構
組織機構
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲全基因組擴增市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。全基因組擴增市場的主要參與者包括 Qiagen NV、LGC Group、Sigma-Aldrich、GE Healthcare。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：全基因組擴增公司的競爭格局

全基因組擴增市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Qiagen NV

公司概況
公司收入
產品
最新動態

LGC Group

公司概況
公司收入
產品
最新動態

Sigma-Aldrich

公司概況
公司收入
產品
最新動態

GE Healthcare

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215177

The global demand for Whole Genome Amplification Market is presumed to reach the market size of nearly USD 7.07 Million by 2032 from USD 3.41 Million in 2023 with a CAGR of 8.44% under the study period 2024-2032.

Whole-genome amplification (WGA) is a process where an entire genome gets amplified. The quantity of DNA which remains in nanograms at the beginning of the process gets converted into micrograms of amplified products. It works on the principles of polymerase chain reaction, which enzymatically replicates the DNA from the genome specimen. WGA is considered an important tool as it increases the limited number of DNA specimens with the help of a small quantity of genomic DNA. It is very useful for studying the gene of an organism, which is done with the conserved limited specimen. This procedure is widely used in a number of applications.

MARKET DYNAMICS

The increasing application of whole genome amplification in various fields is a key factor driving the WGA market. The WGA is expected to witness favorable growth owing to the increasing use of WGA for diagnosing genetic disorders and embryonic disorders, genotyping, forensic, and analysis of old DNA samples. Furthermore, increasing awareness about WGA, a considerable amount of investment for clinical trials and application in molecular biology will contribute to WGA market growth. However, the fact that the result of WGA may vary with two different technologies, namely PCR WGA and REPLI-g, used for sequencing, amplifying, and extracting DNA, will probably hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Whole Genome Amplification. The growth and trends of Whole Genome Amplification industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Whole Genome Amplification market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Single Cell WGA Kit
Complete WGA Kit
WGA Reamplification Kit
WGA & Chip DNA Kit
Others

By Application

Drug Discovery & Development
Disease Diagnosis
Agriculture & Veterinary
Research
Forensics
Others

By End-User

Pharmaceutical & Biotech Companies
Contract Research
Hospitals & Clinics
Research & Academic Institutes
Organizations
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Whole Genome Amplification market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Whole Genome Amplification market include Qiagen NV, LGC Group, Sigma-Aldrich, GE Healthcare. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. WHOLE GENOME AMPLIFICATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Single Cell WGA Kit Historic and Forecast Sales By Regions
5.4. Complete WGA Kit Historic and Forecast Sales By Regions
5.5. WGA Reamplification Kit Historic and Forecast Sales By Regions
5.6. WGA & Chip DNA Kit Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Drug Discovery & Development Historic and Forecast Sales By Regions
6.4. Disease Diagnosis Historic and Forecast Sales By Regions
6.5. Agriculture & Veterinary Historic and Forecast Sales By Regions
6.6. Research Historic and Forecast Sales By Regions
6.7. Forensics Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Pharmaceutical & Biotech Companies Historic and Forecast Sales By Regions
7.4. Contract Research Historic and Forecast Sales By Regions
7.5. Hospitals & Clinics Historic and Forecast Sales By Regions
7.6. Research & Academic Institutes Historic and Forecast Sales By Regions
7.7. Organizations Historic and Forecast Sales By Regions
7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE WHOLE GENOME AMPLIFICATION COMPANIES

9.1. Whole Genome Amplification Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF WHOLE GENOME AMPLIFICATION INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Qiagen NV
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. LGC Group
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sigma-Aldrich
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. GE Healthcare
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments